ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1908

Preliminary Identification of Arthritis-Associated Microbiota in Experimental Spondyloarthritis

Tejpal Gill1, Tri Tran 2, Stephen Brooks 3 and Robert Colbert 4, 1NIAMS/NIH, Bethesda, MD, 2NIAMS, NIH, Bethesda, MD, 3Biomining and Discovery Section/NIAMS/NIH, Bethesda, MD, 4Pediatric Clinical Trials Unit, Pediatric Translational Research Branch, NIAMS, NIH, Bethesda, MD

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: arthritis and inflammation, microbiome, Spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 11, 2019

Title: 4M121: Spondyloarthritis Including Psoriatic Arthritis – Clinical IV: Axial Spondyloarthritis Translational Research (1908–1913)

Session Type: ACR Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Gut microbiota are strongly implicated in the pathogenesis of spondyloarthritis (SpA). Previous studies from our lab have documented extensive gut microbial dysbiosis in rats expressing HLA-B27 and human b2-microglobulin (HLA-B27 TG). The relative abundance of individual microbes is highly dependent on host genetic and environmental differences despite common immune dysregulation, indicating a complex ecological model of dysbiosis that precedes the development of arthritis. Here, we aimed to determine whether HLA-B27 TG rats that develop arthritis have a distinct gut microbial signature and host immune response.

Methods: Cohorts of mixed background (SDM) HLA-B27 TG and wild type (WT) littermates were generated by crossing HLA-B27 TG Lewis with WT Sprague-Dawley rats. SDM animals were monitored for the development of arthritis and euthanized at 4 to 6 months of age. Inflammation in the cecum and colon was assessed by histological scoring. Microbiota profiles were determined using DNA isolated from the cecum lumenal contents by 16S rRNA gene sequencing with primers specified by the Earth Microbiome Project (V4) and Illumina MiSeq. Data were quality-filtered using Quantitative Insights Into Microbial Ecology (QIIME 2). Host gene expression profiles were determined from the cecum tissue samples. RNA was isolated using a standard phenol–chloroform extraction and single-end sequencing of 50 bases was performed using an Illumina HiSeq 2000 system. Transcript expression levels (in reads per kilobase million [RPKM]) were generated and differentially expressed genes were defined for various comparisons.

Results: HLA-B27 TG SDM rats displayed early onset gut inflammation with ~30% developing arthritis by 4 months of age. No arthritis or gut inflammation was seen in WT SDM rats. Cecal and colon histology scores were similar in arthritic vs. non-arthritic HLA-B27 TG rats. There were distinct arthritis-associated microbial that were largely different from gut inflammation associated microbiota found by comparing HLA-B27 TG with WT SDM rats. Arthritic HLA-B27 SDM rats have increased abundance of phylum Bacteroides and Parabacteroides at the expense of Firmicutes. At the species level, the relative frequency of Akkermansia muciniphila and Blautia was increased, while Lachnospiraceae and [Ruminococcus] gnavus were decreased compared to non-arthritic HLA-B27 TG rats. In contrast, cecal host gene expression between HLA-B27 TG arthritic and non-arthritic rats was not significantly different.

Conclusion: We provide a preliminary identification of arthritis associated gut microbiota in HLA-B27 TG rats, which is largely distinct from gut inflammation-associated microbiota. These results may provide valuable insights into the relationship between HLA-B27, gut microbiota, and arthritis in experimental SpA although further studies to determine cause-and-effect relationships are needed.


Disclosure: T. Gill, None; T. Tran, None; S. Brooks, None; R. Colbert, Eli Lilly and Company, 2, 9.

To cite this abstract in AMA style:

Gill T, Tran T, Brooks S, Colbert R. Preliminary Identification of Arthritis-Associated Microbiota in Experimental Spondyloarthritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/preliminary-identification-of-arthritis-associated-microbiota-in-experimental-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/preliminary-identification-of-arthritis-associated-microbiota-in-experimental-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology